share_log

Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.

Benzinga ·  Jul 19, 2022 10:26
Neuronetics shares are trading higher after the company announced its NeuroStar Advanced Therapy for Mental Health received FDA clearance for the treatment of anxious depression.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment